Abstract

Background: Scientific and policy bodies’ failure to acknowledge and act on the evidence base for airborne transmission of SARS-CoV-2 in a timely way is both a mystery and a scandal. In this study, we applied theories from Bourdieu to address the question, “How was a partial and partisan scientific account of SARS-CoV-2 transmission constructed and maintained, leading to widespread imposition of infection control policies which de-emphasised airborne transmission?”. Methods: From one international case study (the World Health Organisation) and four national ones (UK, Canada, USA and Japan), we selected a purposive sample of publicly available texts including scientific evidence summaries, guidelines, policy documents, public announcements, and social media postings. To analyse these, we applied Bourdieusian concepts of field, doxa, scientific capital, illusio, and game-playing. We explored in particular the links between scientific capital, vested interests, and policy influence. Results: Three fields—political, state (policy and regulatory), and scientific—were particularly relevant to our analysis. Political and policy actors at international, national, and regional level aligned—predominantly though not invariably—with medical scientific orthodoxy which promoted the droplet theory of transmission and considered aerosol transmission unproven or of doubtful relevance. This dominant scientific sub-field centred around the clinical discipline of infectious disease control, in which leading actors were hospital clinicians aligned with the evidence-based medicine movement. Aerosol scientists—typically, chemists, and engineers—representing the heterodoxy were systematically excluded from key decision-making networks and committees. Dominant discourses defined these scientists’ ideas and methodologies as weak, their empirical findings as untrustworthy or insignificant, and their contributions to debate as unhelpful. Conclusion: The hegemonic grip of medical infection control discourse remains strong. Exit from the pandemic depends on science and policy finding a way to renegotiate what Bourdieu called the ‘rules of the scientific game’—what counts as evidence, quality, and rigour.

Highlights

  • The droplet v aerosol debate “A good scientist is someone who has a sense of the scientific game”– Pierre Bourdieu[1]When the World Health Organisation (WHO) declared COVID-19 a “pandemic” on 11th March 2020, the virus had already caused 100,000 known cases and 4,000 deaths in 114 countries

  • Orthodoxy and heterodoxy The orthodox position on SARS-CoV-2 transmission, taken by infectious disease researchers, can be summarised as follows

  • Systematic reviews of randomised controlled trials have demonstrated the benefits of handwashing, surface cleansing, and masking of healthcare staff and sick patients but not of masking asymptomatic members of the public, opening windows, or other kinds of ventilation, in respiratory disease prevention. This position upholds the droplet theory of SARS-CoV-2 transmission and supports prevention measures focused on handwashing, physical distancing and selective masking

Read more

Summary

Introduction

The droplet v aerosol debate “A good scientist is someone who has a sense of the scientific game”– Pierre Bourdieu (page 83)[1]When the World Health Organisation (WHO) declared COVID-19 a “pandemic” on 11th March 2020, the virus had already caused 100,000 known cases and 4,000 deaths in 114 countries. You could start by pointing out that this droplet theory is only one possibility, and that there is another one - the aerosol view, and that this alternative/complementary explanation of how Covid-19 is transmitted is absent from such statements, despite there being solid studies, etc. Political and policy actors at international, national, and regional level aligned—predominantly though not invariably—with medical scientific orthodoxy which promoted the droplet theory of transmission and considered aerosol transmission unproven or of doubtful relevance. This dominant scientific sub-field centred around the clinical discipline of infectious disease control, in which leading actors were hospital version 3 (revision)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call